Medical Conditions in Pregnancy: Cervical Insufficiency, Hyperemesis Gravidarum, Anemia, and Diabetes
Cervical Insufficiency (Incompetent Cervix)
- Definition and Overview: Also known as an incompetent cervix, this condition involves premature cervical dilation.
- Diagnosis: Primarily diagnosed via ultrasound.
- Ultrasound Findings:
* Short cervical length.
* Presence of cervical funneling.
- Clinical Risks: Significant risk factors include miscarriage and premature birth.
- Treatment (Cervical Cerclage):
* Prophylactic cervical cerclage is performed to strengthen the cervix.
* Removal Timing: The cerclage must be removed at 36 to 38 weeks of gestation or upon the onset of spontaneous labor.
- Nursing Care and Monitoring:
* Monitor vaginal discharge continuously.
* Instruct the client to immediately report complaints of pressure, contractions, a gush of fluid, vaginal bleeding, or lower back pain.
- Client Education and Activity Restrictions:
* Instruction on strict bedrest.
* Requirement for pelvic rest (avoiding intercourse).
* Maintain high levels of hydration.
* Avoidance of strenuous exercise and heavy lifting.
- Risk Profile: The client is classified as HIGH RISK due to the potential for pregnancy loss or premature birth.
Hyperemesis Gravidarum
- Definition: Excessive, prolonged vomiting during pregnancy.
- Etiology: Possibly linked to elevated levels of the hormone human chorionic gonadotropin (hCG).
- Maternal Complications: Risk of significant weight loss, dehydration, electrolyte imbalance, and nutritional deficiency.
- Fetal Complications: Risk of intrauterine growth restriction (IUGR), being small for gestational age (SGA), and preterm birth.
- Risk Factors:
* Advanced maternal age.
* Multifetal pregnancy (e.g., twins).
* Gestational trophoblastic disease.
* Hyperthyroidism.
* Diabetes.
* Family history of hyperemesis.
* Gastrointestinal disorders.
* High levels of stress.
- Medical Treatment:
* FDA-approved medication for nausea and vomiting in pregnancy: doxylamine/pyridoxine (Diclegis).
* Hospital admission may be required for IV hydration depending on the severity.
- Nutritional Management:
* Initiate a clear liquid diet and advance to a bland diet as vomiting subsides.
* Enteral nutrition may be administered in severe cases.
Iron-Deficiency Anemia
- Pathophysiology: Occurs due to inadequate maternal iron stores and insufficient dietary iron intake to meet the demands of pregnancy.
- Diagnostic Criteria:
* First and Second Trimester: Hemoglobin (Hgb) <11.0,mg/dl.
* Third Trimester: Hemoglobin (Hgb) <10.5,mg/dl.
* Hematocrit (HCT): <33%.
* Ferritin: <12,mcg/L.
- Symptoms: Fatigue, weakness, and Pica (craving non-nutritive substances).
- Risk Factors: Short intervals between pregnancies (close interval pregnancies), heavy menstrual periods prior to pregnancy, and poor dietary iron intake.
- Treatment: Administration of supplemental elemental iron (PO).
- Nursing Care and Dietary Recommendations:
* Standard pregnancy recommendation for iron: 27,mg/day.
* Standard prenatal vitamins typically contain 30,mg/day.
* Therapeutic dose for diagnosed Iron-Deficiency Anemia: Increase daily intake to 60−120,mg/day.
- Patient Education for Supplementation:
* Ferrous sulfate supplements should be taken on an empty stomach.
* Consume with orange juice to increase absorption.
* Increase intake of iron-rich foods.
* Increase fiber and fluid intake to mitigate the discomfort of constipation caused by iron supplements.
Gestational Diabetes Mellitus (GDM)
- Definition: Glucose intolerance with its first onset or recognition during pregnancy.
- Pathophysiology: A disorder characterized by insufficient insulin production by the pancreas to move glucose from the blood into the cells.
- Ketoacidosis: When the body cannot utilize glucose, it metabolizes protein and fat for energy, leading to the accumulation of ketones and acid (ketoacidosis).
- Postpartum Prognosis: In instances of true GDM, glucose levels should return to normal by 6 weeks postpartum.
- Preexisting Diabetes Mellitus:
* Clients with diabetes prior to pregnancy face an increased risk of delivering a newborn with congenital anomalies.
* Major risk for congenital anomalies stems from maternal hyperglycemia during the early embryonic period of pregnancy.
Complications and High-Risk Factors in Diabetic Pregnancy
- Maternal Effects:
* Spontaneous abortion.
* Gestational hypertension.
* Preterm labor.
* Polyhydramnios.
* Vaginitis and urinary tract infections (UTIs).
* Birth canal injury related to the large size of the fetus.
* Ketoacidosis.
- Fetal Effects:
* Congenital abnormalities.
* Respiratory distress syndrome (RDS).
* Birth injury.
* Neonatal hypoglycemia, hypocalcemia, and hyperbilirubinemia.
* Macrosomia: Defined as a large fetus weighing 4000−4500,gram (approximately 9,lb or greater).
* Perinatal death.
- High-Risk Maternal Factors for GDM:
* Maternal obesity (BMI>30).
* History of macrosomia.
* Maternal age >25 years.
* Previous history of a child with anomalies or stillbirth.
* Personal history of GDM or family history of diabetes.
* Fasting glucose >126,mg/dl or postprandial glucose >200,mg/dl.
Screening and Clinical Monitoring for GDM
- Screening Intervals:
* Early glucose tolerance testing for clients with BMI>30 as part of prenatal labs.
* Standard 1-hour glucose test performed at 24−28 weeks gestation.
- Thresholds & Follow-up:
* A 1-hour blood glucose level of 130−140,mg/dl indicates the need for a 3-hour glucose tolerance test.
- Ongoing Monitoring:
* Monitoring urine ketones is recommended, as ketoacidosis can be fatal to the fetus.
* Education on self-monitoring of blood glucose (SMBG).
* Referrals to Endocrinology or Maternal-Fetal Medicine (MFM).
- Target Blood Glucose Levels in Pregnancy:
* Fasting: <95,mg/dl.
* 1-hour postprandial: 130−140,mg/dl.
* 2-hour postprandial: <120,mg/dl.
Comparison of Hypoglycemia and Hyperglycemia
- Hypoglycemia:
* Blood glucose level: <60,mg/dl.
* Symptoms: Nervousness, headache, hunger, irritability, blurred vision, lethargy, moist skin, pallor, sweating, and loss of consciousness.
* Corrective Measures: Consume fruit, crackers, milk, or juice. Requires adjustment of insulin or dietary intake.
- Hyperglycemia:
* Blood glucose level: >120,mg/dl.
* Symptoms: Polydipsia (excessive thirst), polyphagia (excessive hunger), polyuria (excessive urination), nausea, flushed/dry skin, "fruity breath," dry mouth, weight loss, deep respirations, and depressed reflexes.
* Corrective Measures: Modify dietary intake, adjust insulin, treat infections promptly, and exercise regularly.
Fetal Assessment and Management of GDM
- Fetal Assessment Tools:
* Non-stress testing (NST).
* Biophysical profile (BPP) if the NST is nonreactive.
* Amniocentesis to measure fetal lung maturity.
* Ultrasound to monitor growth patterns and evaluate amniotic fluid volume.
- Pharmacological Management:
* Oral hypoglycemics: Glyburide is considered safe in pregnancy as it does not cross the placenta. Metformin is also used.
* Insulin: Dosages are tailored to individual needs, often using a sliding scale.
- Insulin Dynamics During Pregnancy:
* Needs increase during the second trimester due to increased placental hormones and insulin resistance.
* Needs may decrease in the third trimester.
* Dosage changes during labor; IV dextrose may be necessary to support blood levels.
- Client Education:
* Daily kick counts/fetal movement monitoring.
* Diet and exercise regimens.
* Self-administration of insulin.
* Management of hypoglycemia and hyperglycemia.
* Breastfeeding education: Infants who are exclusively breastfed have a decreased risk of developing diabetes later in life.
References
- Leifer ED 9, Chapter 5.
- ATI ED 12.0, PN Maternal Newborn Nursing, Chapter 8.